Krüsmann W, Slanina J, Nolte I
Department of Hematology and Oncology, University Medical School, Freiburg.
Strahlenther Onkol. 1990 Apr;166(4):265-70.
In patients with Hodgkin's disease, the serum IgE concentrations were determined with the PRIST radioimmunoassay before commencing and after ending systemic megavoltage radiotherapy. 57 patients showed mainly raised serum IgE concentrations before radiotherapy. After the end of radiotherapy, 44 patients were investigated, and a highly significant fall of the IgE concentration was shown in the serum following the radiotherapy. The decrease of IgE concentration was most pronounced in the patients in whom large areas of irradiation were necessary or who displayed B symptoms. In a proportion of the patients, the IgE concentration in the serum could be measured once more six and twelve months after the end of radiotherapy. Although the IgE concentrations rose again after radiotherapy, the initial values before the beginning of radiotherapy had not yet been reached again even twelve months after treatment in 21 patients investigated. A long-lasting immunosuppressant effect of radiotherapy on the serum IgE concentration could thus be demonstrated which corresponds to the effect on the serum IgM concentration described earlier.
在霍奇金病患者中,在开始全身大剂量放疗前及结束后,采用PRIST放射免疫分析法测定血清IgE浓度。57例患者放疗前血清IgE浓度主要升高。放疗结束后,对44例患者进行了调查,结果显示放疗后血清中IgE浓度显著下降。IgE浓度下降在需要大面积照射或有B症状的患者中最为明显。部分患者在放疗结束后6个月和12个月可再次测量血清IgE浓度。虽然放疗后IgE浓度再次升高,但在接受调查的21例患者中,即使在治疗12个月后仍未再次达到放疗开始前的初始值。因此,可以证明放疗对血清IgE浓度具有持久的免疫抑制作用,这与先前描述的对血清IgM浓度的作用相对应。